source
- GSK gains another cancer drug approval and unveils promising chemo data as it prepares for lung cancer approvalGSK received regulatory approval this week for one of its cancer medicines in an additional tumor indication, expanding the portfolio that has grown since the company re-entered oncology a decade a…
- Biotech IPOs Pull in $7.5B Across 22 Deals in 2026, While Market Gains Stall in Q3Biopharma companies raised about $7.5 billion from 22 initial public offerings in the first three quarters of 2026, according to J.P. Morgan data. This level of financing far exceeds the eight offe…